Supernus Pharmaceuticals, Inc.
SUPN
$32.15
$0.451.42%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 55.71% | 77.97% | 101.41% | 128.93% | 30.26% |
| Total Receivables | -1.42% | -1.44% | 2.57% | 11.67% | 2.90% |
| Inventory | -34.17% | -29.86% | -23.36% | -24.74% | -17.63% |
| Prepaid Expenses | 21.70% | 116.41% | 14.53% | -48.25% | 45.85% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 26.32% | 39.13% | 42.43% | 39.54% | -38.38% |
|
|
|||||
| Total Current Assets | 26.32% | 39.13% | 42.43% | 39.54% | -38.38% |
| Net Property, Plant & Equipment | -20.26% | -15.29% | -12.01% | -7.60% | -4.29% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | -13.39% | -13.00% | -15.75% | -15.51% | -15.05% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -24.60% | -17.17% | -19.26% | -13.06% | -15.18% |
| Total Assets | 3.31% | 7.08% | 4.48% | 1.76% | -27.22% |
|
|
|||||
| Total Accounts Payable | -50.88% | 133.55% | 88.61% | 5.18% | 24.71% |
| Total Accrued Expenses | 7.94% | 8.39% | -1.63% | 9.94% | -2.56% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -34.99% | -17.31% | 8.81% | 20.75% | -97.79% |
| Total Finance Division Other Current Liabilities | -29.72% | -11.38% | 3.05% | 52.02% | 129.50% |
| Total Other Current Liabilities | -29.72% | -11.38% | 3.05% | 52.02% | 129.50% |
| Total Current Liabilities | -10.42% | 0.76% | 1.38% | 22.20% | -57.00% |
|
|
|||||
| Total Current Liabilities | -10.42% | 0.76% | 1.38% | 22.20% | -57.00% |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -20.08% | -17.51% | -14.52% | -11.36% | -9.63% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -69.15% | -61.66% | -70.70% | -77.52% | -75.47% |
| Total Liabilities | -15.56% | -6.69% | -10.03% | -3.97% | -57.38% |
|
|
|||||
| Common Stock & APIC | 8.78% | 9.09% | 7.86% | 7.28% | 7.38% |
| Retained Earnings | 12.83% | 15.31% | 12.40% | 1.05% | -3.11% |
| Treasury Stock & Other | 70.22% | 68.13% | 106.47% | 79.04% | 77.07% |
| Total Common Equity | 10.93% | 12.39% | 10.41% | 4.08% | 1.87% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.93% | 12.39% | 10.41% | 4.08% | 1.87% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.93% | 12.39% | 10.41% | 4.08% | 1.87% |
|
|
|||||